Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 10-year trajectories of depressive symptoms and risk of dementia: a population-based study.1 passage
• 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.1 passage
• 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.1 passage
• A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern Europe.1 passage
• A brief psychological intervention to reduce repetition of self-harm in patients admitted to hospital following a suicide attempt: a randomised controlled trial.1 passage
• A large-scale genome-wide association study meta-analysis of cannabis use disorder.1 passage
• A partnership for transforming mental health globally.1 passage
• A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management.1 passage
• A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies.1 passage
• A population-based analysis of suicidality and its correlates: findings from the National Mental Health Survey of India, 2015-16.1 passage
• ADHD in children and young people: prevalence, care pathways, and service provision.1 passage
• AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial.1 passage
• Accounting for mental health research funding: developing a quantitative baseline of global investments.1 passage
• Addressing the public mental health challenge of COVID-19.1 passage
• Admission to acute mental health services after contact with crisis resolution and home treatment teams: an investigation in two large mental health-care providers.1 passage
• Adult attention-deficit hyperactivity disorder: key conceptual issues.1 passage
• Adult mental health consequences of peer bullying and maltreatment in childhood: two cohorts in two countries.1 passage
• Advancing urban mental health research: from complexity science to actionable targets for intervention.1 passage
• Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.1 passage
• Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.1 passage
• Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.1 passage
• An active inference perspective on the negative symptoms of schizophrenia.1 passage
• An evidence map of psychosocial interventions for the earliest stages of bipolar disorder.1 passage
• An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.1 passage
• Anorexia nervosa: aetiology, assessment, and treatment.1 passage
• Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.1 passage
• Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.1 passage
• Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.1 passage
• Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.1 passage
• Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.1 passage
• Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.1 passage
• Architecture and functioning of child and adolescent mental health services: a 28-country survey in Europe.1 passage
• Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives.1 passage
• Art therapy for people with psychosis: a narrative review of the literature.1 passage
• Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study.1 passage
• Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study.1 passage
• Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.1 passage
• Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study.1 passage
• Association of disrupted circadian rhythmicity with mood disorders, subjective wellbeing, and cognitive function: a cross-sectional study of 91 105 participants from the UK Biobank.1 passage
• Association of neighbourhood migrant density and risk of non-affective psychosis: a national, longitudinal cohort study.1 passage
• Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study of children and young people in Wales, UK.1 passage
• Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.1 passage
• Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study.1 passage
• Associations between life-course-persistent antisocial behaviour and brain structure in a population-representative longitudinal birth cohort.1 passage
• Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study.1 passage
• Associations between significant head injury and persisting disability and violent crime in women in prison in Scotland, UK: a cross-sectional study.1 passage
• Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study.1 passage
• Associations of mental distress with residency in conflict zones, ethnic minority status, and potentially modifiable social factors following conflict in Sri Lanka: a nationwide cross-sectional study.1 passage
• Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.1 passage
• Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial.1 passage
• Automation to optimise physician treatment of individual patients: examples in psychiatry.1 passage
• Barriers and facilitators of mental health programmes in primary care in low-income and middle-income countries.1 passage
• Barriers and facilitators to implementing perinatal mental health care in health and social care settings: a systematic review.1 passage
• Barriers to medication entitlements after diagnosis of ADHD.1 passage
• Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial.1 passage
• Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.1 passage
• Blood tests to diagnose schizophrenia: self-imposed limits in psychiatry.1 passage
• Brain microglia in psychiatric disorders.1 passage
• Brain-based mediation of non-conscious reduction of phobic avoidance in young women during functional MRI: a randomised controlled experiment.1 passage
• Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.1 passage
• Building capacity for global mental health research: challenges to balancing clinical and research training.1 passage
• Bullying by peers in childhood and effects on psychopathology, suicidality, and criminality in adulthood.1 passage
• Bullying in the family: sibling bullying.1 passage
• Bullying victimisation and risk of psychotic phenomena: analyses of British national survey data.1 passage
• Burden, impact, and needs of caregivers of children living with mental health or neurodevelopmental conditions in low-income and middle-income countries: a scoping review.1 passage
• Burden, risk factors, and comorbidities of behavioural and emotional problems in Kenyan children: a population-based study.1 passage
• C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis.1 passage
• COVID-19 and UK family carers: policy implications.1 passage
• COVID-19 and involuntary hospitalisation: navigating the challenge.1 passage
• COVID-19 and the Blitz compared: mental health outcomes in the UK.1 passage
• COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.1 passage
• COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health.1 passage
• COVID-19 vaccination for people with severe mental illness: why, what, and how?1 passage
• Can a criminal justice alcohol abstention programme with swift, certain, and modest sanctions (24/7 Sobriety) reduce population mortality? A retrospective observational study.1 passage
• Can neuroimaging be used to predict the onset of psychosis?1 passage
• Can we make cannabis safer?1 passage
• Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.1 passage
• Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.1 passage
• Catatonia and the immune system: a review.1 passage
• Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study.1 passage
• Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.1 passage
• Changes in mental state and behaviour in Huntington's disease.1 passage
• Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis.1 passage
• Characteristics of trafficked adults and children with severe mental illness: a historical cohort study.1 passage
• Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis.1 passage
• Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology.1 passage
• Childbirth and prevention of bipolar disorder: an opportunity for change.1 passage
• Childhood maltreatment and non-suicidal self-injury: a systematic review and meta-analysis.1 passage
• Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis.1 passage
• Childhood: a suitable case for treatment?1 passage
• Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention.1 passage
• Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.1 passage
• Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial.1 passage
• Clinical and social factors associated with increased risk for involuntary psychiatric hospitalisation: a systematic review, meta-analysis, and narrative synthesis.1 passage
• Clinical effectiveness and acceptability of structured group psychoeducation versus optimised unstructured peer support for patients with remitted bipolar disorder (PARADES): a pragmatic, multicentre, observer-blind, randomised controlled superiority trial.1 passage
• Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.1 passage
• Clinical effectiveness of a staff training intervention in mental health inpatient rehabilitation units designed to increase patients' engagement in activities (the Rehabilitation Effectiveness for Activities for Life [REAL] study): single-blind, cluster-randomised controlled trial.1 passage
• Clinical efficacy of a Decision Support Tool (Link-me) to guide intensity of mental health care in primary practice: a pragmatic stratified randomised controlled trial.1 passage
• Clinical management of comorbid diabetes and psychotic disorders.1 passage
• Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial.1 passage
• Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium.1 passage
• Clinical relevance of appraisals of persistent psychotic experiences in people with and without a need for care: an experimental study.1 passage
• Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.1 passage
• Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.1 passage
• Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.1 passage
• Cognitive function following a major depressive episode: a systematic review and meta-analysis.1 passage
• Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study.1 passage
• Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.1 passage
• Commercial pharmacogenetic-based decision-support tools in psychiatry.1 passage
• Common elements of evidence-based systemic treatments for adolescents with disruptive behaviour problems.1 passage
• Common versus specific factors in psychotherapy: opening the black box.1 passage
• Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis.1 passage
• Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.1 passage
• Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis.1 passage
• Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.1 passage
• Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.1 passage
• Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial.1 passage
• Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial.1 passage
• Comparison of effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies: a randomised controlled trial.1 passage
• Compensatory strategies below the behavioural surface in autism: a qualitative study.1 passage
• Compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness: a systematic review and meta-analysis.1 passage
• Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey.1 passage
• Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.1 passage
• Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework.1 passage
• Cost-effectiveness of care for people with psychosis in the community and psychiatric hospitals in the Czech Republic: an economic analysis.1 passage
• Cross-trial prediction of treatment outcome in depression: a machine learning approach.1 passage
• Curtailing the communicability of psychiatric disorders.1 passage
• Cytokine concentrations throughout pregnancy and risk for psychosis in adult offspring: a longitudinal case-control study.1 passage
• D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial.1 passage
• Data science for mental health: a UK perspective on a global challenge.1 passage
• Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial.1 passage
• Delivering the Thinking Healthy Programme for perinatal depression through peers: an individually randomised controlled trial in India.1 passage
• Delivering the Thinking Healthy Programme for perinatal depression through volunteer peers: a cluster randomised controlled trial in Pakistan.1 passage
• Delusions beyond beliefs: a critical overview of diagnostic, aetiological, and therapeutic schizophrenia research from a clinical-phenomenological perspective.1 passage
• Depression and violence: a Swedish population study.1 passage
• Depression care management for adults older than 60 years in primary care clinics in urban China: a cluster-randomised trial.1 passage
• Depressive symptoms and objectively measured physical activity and sedentary behaviour throughout adolescence: a prospective cohort study.1 passage
• Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study.1 passage
• Detection and treatment of at-risk mental state for developing a first psychosis: making up the balance.1 passage
• Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.1 passage
• Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis.1 passage
• Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.1 passage
• Diagnosis, prognosis, and treatment of brief psychotic episodes: a review and research agenda.1 passage
• Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature.1 passage
• Direct versus indirect psychosocial and behavioural interventions to prevent suicide and suicide attempts: a systematic review and meta-analysis.1 passage
• Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data.1 passage
• Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.1 passage
• Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in severe mental illness in the Paisa population: a case-control study.1 passage
• Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.1 passage
• Does tobacco use cause psychosis? Systematic review and meta-analysis.1 passage
• Early intervention for depression in young people: a blind spot in mental health care.1 passage
• Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials.1 passage
• Economic analyses of mental health and substance use interventions in the workplace: a systematic literature review and narrative synthesis.1 passage
• Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.1 passage
• Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study.1 passage
• Effect of an early perinatal depression intervention on long-term child development outcomes: follow-up of the Thinking Healthy Programme randomised controlled trial.1 passage
• Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.1 passage
• Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study.1 passage
• Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.1 passage
• Effect of implementation of a smoke-free policy on physical violence in a psychiatric inpatient setting: an interrupted time series analysis.1 passage
• Effect of increased compulsion on readmission to hospital or disengagement from community services for patients with psychosis: follow-up of a cohort from the OCTET trial.1 passage
• Effectiveness of a peer-delivered, psychosocial intervention on maternal depression and child development at 3 years postnatal: a cluster randomised trial in Pakistan.1 passage
• Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention.1 passage
• Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial.1 passage
• Effectiveness of digital psychological interventions for mental health problems in low-income and middle-income countries: a systematic review and meta-analysis.1 passage
• Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.1 passage
• Effectiveness of psychological interventions in prison to reduce recidivism: a systematic review and meta-analysis of randomised controlled trials.1 passage
• Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial.1 passage
• Effectiveness of the parent-mediated intervention for children with autism spectrum disorder in south Asia in India and Pakistan (PASS): a randomised controlled trial.1 passage
• Effectiveness of traditional healers in treating mental disorders: a systematic review.1 passage
• Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.1 passage
• Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.1 passage
• Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.1 passage
• Effects of institutional rearing and foster care on psychopathology at age 12 years in Romania: follow-up of an open, randomised controlled trial.1 passage
• Effects of sleep deprivation on inhibitory biomarkers of schizophrenia: implications for drug development.1 passage
• Effects of the COVID-19 pandemic on the mental health of prisoners.1 passage
• Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial.1 passage
• Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.1 passage
• Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.1 passage
• Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.1 passage
• Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study.1 passage
• Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial.1 passage
• Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis.1 passage
• Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study.1 passage
• Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review.1 passage
• Electroconvulsive therapy and risk of dementia in patients with affective disorders: a cohort study.1 passage
• Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials.1 passage
• Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence.1 passage
• Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review.1 passage
• Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries.1 passage
• Equity effects of parenting interventions for child conduct problems: a pan-European individual participant data meta-analysis.1 passage
• Estimating the true global burden of mental illness.1 passage
• Ethnic density and other neighbourhood associations for mortality in severe mental illness: a retrospective cohort study with multi-level analysis from an urbanised and ethnically diverse location in the UK.1 passage
• Ethnic variations in compulsory detention under the Mental Health Act: a systematic review and meta-analysis of international data.1 passage
• Ethnicity and excess mortality in severe mental illness: a cohort study.1 passage
• Experiences of hearing voices: analysis of a novel phenomenological survey.1 passage
• Experiencing mental health diagnosis: a systematic review of service user, clinician, and carer perspectives across clinical settings.1 passage
• Extra-axial cerebrospinal fluid in high-risk and normal-risk children with autism aged 2-4 years: a case-control study.1 passage
• Factors affecting implementation of digital health interventions for people with psychosis or bipolar disorder, and their family and friends: a systematic review.1 passage
• Feedback-informed treatment versus usual psychological treatment for depression and anxiety: a multisite, open-label, cluster randomised controlled trial.1 passage
• Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.1 passage
• Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.1 passage
• Formal thought disorders: from phenomenology to neurobiology.1 passage
• Functional cognitive disorders: a systematic review.1 passage
• Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.1 passage
• Gender incongruence of childhood in the ICD-11: controversies, proposal, and rationale.1 passage
• Gene-environment correlations and causal effects of childhood maltreatment on physical and mental health: a genetically informed approach.1 passage
• General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis.1 passage
• Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.1 passage
• Glial cells in schizophrenia: a unified hypothesis.1 passage
• Global lessons for deinstitutionalisation from the ill-fated transfer of mental health-care users in Gauteng, South Africa.1 passage
• Global mental health and neuroscience: potential synergies.1 passage
• Harnessing emotional mental imagery to reduce anxiety and depression in young people: an integrative review of progress and promise.1 passage
• Health services, suicide, and self-harm: patient distress and system anxiety.1 passage
• Heterogeneity of postpartum depression: a latent class analysis.1 passage
• Hispanic immigrants in the USA: social and mental health perspectives.1 passage
• Hospital management of suicidal behaviour and subsequent mortality: a prospective cohort study.1 passage
• Hospital presentations for self-poisoning during COVID-19 in Sri Lanka: an interrupted time-series analysis.1 passage
• How do antidepressants work? New perspectives for refining future treatment approaches.1 passage
• How leisure activities affect health: a narrative review and multi-level theoretical framework of mechanisms of action.1 passage
• How mental health care should change as a consequence of the COVID-19 pandemic.1 passage
• How much is spent on mental health research: developing a system for categorising grant funding in the UK.1 passage
• How to inform the public about protective actions in a nuclear or radiological incident: a systematic review.1 passage
• Identification of low risk of violent crime in severe mental illness with a clinical prediction tool (Oxford Mental Illness and Violence tool [OxMIV]): a derivation and validation study.1 passage
• Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey.1 passage
• Identifying research priorities for digital technology in mental health care: results of the James Lind Alliance Priority Setting Partnership.1 passage
• Identifying the lost generation of adults with autism spectrum conditions.1 passage
• Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study.1 passage
• Impairments of motor function among children with a familial risk of schizophrenia or bipolar disorder at 7 years old in Denmark: an observational cohort study.1 passage
• Improving classification of psychoses.1 passage
• In-utero and perinatal influences on suicide risk: a systematic review and meta-analysis.1 passage
• Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the iceberg model of self-harm): a retrospective study.1 passage
• Income inequality and mental illness-related morbidity and resilience: a systematic review and meta-analysis.1 passage
• Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.1 passage
• Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.1 passage
• Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.1 passage
• Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies.1 passage
• Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies.1 passage
• Insomnia disorder subtypes derived from life history and traits of affect and personality.1 passage
• Integrated care for people with long-term mental and physical health conditions in low-income and middle-income countries.1 passage
• Integrating clinical staging and phenomenological psychopathology to add depth, nuance, and utility to clinical phenotyping: a heuristic challenge.1 passage
• Integrating youth mental health into cash transfer programmes in response to the COVID-19 crisis in low-income and middle-income countries.1 passage
• Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes.1 passage
• International consensus on a standard set of outcome measures for child and youth anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder.1 passage
• Internet-based behavioural activation with lay counsellor support versus online minimal psychoeducation without support for treatment of depression: a randomised controlled trial in Indonesia.1 passage
• Interventions to reduce suicides at suicide hotspots: a systematic review and meta-analysis.1 passage
• Interventions to reduce symptoms of common mental disorders and suicidal ideation in physicians: a systematic review and meta-analysis.1 passage
• Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.1 passage
• Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.1 passage
• LGBTQ+ focused mental health research strategy in response to COVID-19.1 passage
• Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis.1 passage
• Limb amputation and other disability desires as a medical condition.1 passage
• Long versus short pulse width subcallosal cingulate stimulation for treatment-resistant depression: a randomised, double-blind, crossover trial.1 passage
• Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.1 passage
• Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study.1 passage
• Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.1 passage
• Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.1 passage
• Long-term effects of rent supplements and mental health support services on housing and health outcomes of homeless adults with mental illness: extension study of the At Home/Chez Soi randomised controlled trial.1 passage
• Long-term outcomes following self-poisoning in adolescents: a population-based cohort study.1 passage
• Long-term outcomes of childhood sexual abuse: an umbrella review.1 passage
• Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study.1 passage
• Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study.1 passage
• Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study.1 passage
• Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study.1 passage
• Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.1 passage
• Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies.1 passage
• Maternal depression and mental health in early childhood: an examination of underlying mechanisms in low-income and middle-income countries.1 passage
• Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis.1 passage
• Maternal perinatal depressive symptoms and offspring psychotic experiences at 18 years of age: a longitudinal study.1 passage
• Maternal prenatal depressive symptoms and risk for early-life psychopathology in offspring: genetic analyses in the Norwegian Mother and Child Birth Cohort Study.1 passage
• Mechanistic insights into the genetics of affective psychosis from Prader-Willi syndrome.1 passage
• Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study.1 passage
• Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.1 passage
• Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.1 passage
• Memory boundaries: opening a window inspired by reconsolidation to treat anxiety, trauma-related, and addiction disorders.1 passage
• Mendelian randomisation for nutritional psychiatry.1 passage
• Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.1 passage
• Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.1 passage
• Mental health care for international Chinese students affected by the COVID-19 outbreak.1 passage
• Mental health care for medical staff in China during the COVID-19 outbreak.1 passage
• Mental health in Zimbabwe: a health systems analysis.1 passage
• Mental health of prisoners: prevalence, adverse outcomes, and interventions.1 passage
• Mental health research in the Arab region: challenges and call for action.1 passage
• Mental health research priorities for Europe.1 passage
• Mental health resilience in the adolescent offspring of parents with depression: a prospective longitudinal study.1 passage
• Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data.1 passage
• Mental health service changes, organisational factors, and patient suicide in England in 1997-2012: a before-and-after study.1 passage
• Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis.1 passage
• Mental health training for health workers in Africa: a systematic review.1 passage
• Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies.1 passage
• Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study.1 passage
• Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.1 passage
• Mitigating the effect of persistent postnatal depression on child outcomes through an intervention to treat depression and improve parenting: a randomised controlled trial.1 passage
• Modelling suicide and unemployment: a longitudinal analysis covering 63 countries, 2000-11.1 passage
• Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.1 passage
• Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.1 passage
• Motivation and methods of external organisations investing in mental health in low-income and middle-income countries: a qualitative study.1 passage
• Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms.1 passage
• Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.1 passage
• Multiple adverse outcomes following first discharge from inpatient psychiatric care: a national cohort study.1 passage
• Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.1 passage
• Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): 5-year follow-up of a pragmatic, randomised, controlled, superiority trial.1 passage
• Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trial.1 passage
• NICE guidance on psychological treatments for bipolar disorder: searching for the evidence.1 passage
• Negative symptoms of schizophrenia: new developments and unanswered research questions.1 passage
• Neural origins of psychosocial functioning impairments in major depression.1 passage
• Neurobiological perspective of 22q11.2 deletion syndrome.1 passage
• Neurobiology of addiction: a neurocircuitry analysis.1 passage
• Neurocircuitry basis of the opioid use disorder-post-traumatic stress disorder comorbid state: conceptual analyses using a dimensional framework.1 passage
• Neurodevelopment and ages of onset in depressive disorders.1 passage
• Neurodevelopmental disorders.1 passage
• Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.1 passage
• Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.1 passage
• Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.1 passage
• Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomes.1 passage
• Neuropsychiatric aspects of concussion.1 passage
• Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis.1 passage
• Neuroscience in gambling policy and treatment: an interdisciplinary perspective.1 passage
• New perspectives on schizophrenia in later life: implications for treatment, policy, and research.1 passage
• Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial.1 passage
• Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.1 passage
• Nutritional medicine as mainstream in psychiatry.1 passage
• Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses.1 passage
• Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study.1 passage
• Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.1 passage
• Parent-mediated intervention versus no intervention for infants at high risk of autism: a parallel, single-blind, randomised trial.1 passage
• Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses.1 passage
• Pathways to perinatal depressive symptoms after mass conflict in Timor-Leste: a modelling analysis using cross-sectional data.1 passage
• Patient-reported depression measures in cancer: a meta-review.1 passage
• Persecutory delusions: a cognitive perspective on understanding and treatment.1 passage
• Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.1 passage
• Perspectives of lived experience across continents: our reality and call for universal health coverage.1 passage
• Perspectives on ICD-11 to understand and improve mental health diagnosis using expertise by experience (INCLUDE Study): an international qualitative study.1 passage
• Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health.1 passage
• Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.1 passage
• Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.1 passage
• Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.1 passage
• Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis.1 passage
• Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.1 passage
• Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe.1 passage
• Placebo eff ects in psychiatry: mediators and moderators.1 passage
• Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.1 passage
• Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.1 passage
• Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.1 passage
• Post-partum psychosis and its association with bipolar disorder in the UK: a case-control study using polygenic risk scores.1 passage
• Post-traumatic stress disorder and cancer.1 passage
• Post-traumatic stress disorder and cardiovascular disease.1 passage
• Post-traumatic stress symptoms 5 years after military deployment to Afghanistan: an observational cohort study.1 passage
• Pre-migration and post-migration factors associated with mental health in humanitarian migrants in Australia and the moderation effect of post-migration stressors: findings from the first wave data of the BNLA cohort study.1 passage
• Precision psychiatry: a neural circuit taxonomy for depression and anxiety.1 passage
• Prediction of violent reoffending on release from prison: derivation and external validation of a scalable tool.1 passage
• Predictors of future suicide attempt among adolescents with suicidal thoughts or non-suicidal self-harm: a population-based birth cohort study.1 passage
• Predictors of persistence of anxiety disorders across the lifespan: a systematic review.1 passage
• Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study.1 passage
• Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.1 passage
• Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study.1 passage
• Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden.1 passage
• Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis.1 passage
• Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.1 passage
• Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis.1 passage
• Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study.1 passage
• Prevalence of mental disorders in China: a cross-sectional epidemiological study.1 passage
• Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis.1 passage
• Prevalence of non-suicidal self-harm and service contact in England, 2000-14: repeated cross-sectional surveys of the general population.1 passage
• Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study.1 passage
• Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study.1 passage
• Prevention, early intervention, harm reduction, and treatment of substance use in young people.1 passage
• Prevention, screening, and treatment for heavy drinking and alcohol use disorder.1 passage
• Preventive strategies for mental health.1 passage
• Principles for designing the built environment of mental health services.1 passage
• Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.1 passage
• Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.1 passage
• Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.1 passage
• Psychiatric comorbidities in alcohol use disorder.1 passage
• Psychiatric disorders and suicide attempts in Swedish survivors of the 2004 southeast Asia tsunami: a 5 year matched cohort study.1 passage
• Psychiatric disorders and violent reoffending: a national cohort study of convicted prisoners in Sweden.1 passage
• Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme.1 passage
• Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.1 passage
• Psychodynamic therapy meets evidence-based medicine: a systematic review using updated criteria.1 passage
• Psychological interventions for common mental disorders in women experiencing intimate partner violence in low-income and middle-income countries: a systematic review and meta-analysis.1 passage
• Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis.1 passage
• Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.1 passage
• Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis.1 passage
• Psychotherapy for depression in older veterans via telemedicine: a randomised, open-label, non-inferiority trial.1 passage
• Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study.1 passage
• Public health messaging and harm reduction in the time of COVID-19.1 passage
• Punishment and psychopathy: a case-control functional MRI investigation of reinforcement learning in violent antisocial personality disordered men.1 passage
• Quality of life, autonomy, satisfaction, and costs associated with mental health supported accommodation services in England: a national survey.1 passage
• Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.1 passage
• REFOCUS-PULSAR recovery-oriented practice training in specialist mental health care: a stepped-wedge cluster randomised controlled trial.1 passage
• Racial and ethnic differences in perception of provider cultural competence among patients with depression and anxiety symptoms: a retrospective, population-based, cross-sectional analysis.1 passage
• Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis.1 passage
• Reasons for endorsing or rejecting self-binding directives in bipolar disorder: a qualitative study of survey responses from UK service users.1 passage
• Recognising and addressing the impact of COVID-19 on obsessive-compulsive disorder.1 passage
• Reduction in adolescent depression after contact with mental health services: a longitudinal cohort study in the UK.1 passage
• Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review.1 passage
• Register-based metrics of years lived with disability associated with mental and substance use disorders: a register-based cohort study in Denmark.1 passage
• Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial.1 passage
• Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.1 passage
• Relative age within the school year and diagnosis of attention-deficit hyperactivity disorder: a nationwide population-based study.1 passage
• Removing transgender identity from the classification of mental disorders: a Mexican field study for ICD-11.1 passage
• Resilience and mental health: how multisystemic processes contribute to positive outcomes.1 passage
• Reversing hard won victories in the name of human rights: a critique of the General Comment on Article 12 of the UN Convention on the Rights of Persons with Disabilities.1 passage
• Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications.1 passage
• Rheumatoid arthritis and depression: an inflammatory perspective.1 passage
• Risk and protective factors for childhood suicidality: a US population-based study.1 passage
• Risk factors for self-harm in prison: a systematic review and meta-analysis.1 passage
• Risk of depression and self-harm in teenagers identifying with goth subculture: a longitudinal cohort study.1 passage
• Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong, 2000-10: a nested case-control study.1 passage
• Risk of serious medical events in patients with depression treated with electroconvulsive therapy: a propensity score-matched, retrospective cohort study.1 passage
• Risk of suicide and repeat self-harm after hospital attendance for non-fatal self-harm in Sri Lanka: a cohort study.1 passage
• Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.1 passage
• Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.1 passage
• Scaling-up treatment of depression and anxiety: a global return on investment analysis.1 passage
• Scenarios for the future of mental health care: a social perspective.1 passage
• Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study.1 passage
• School-based interventions to prevent anxiety and depression in children and young people: a systematic review and network meta-analysis.1 passage
• Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.1 passage
• Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis.1 passage
• Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark.1 passage
• Self-disorders and psychopathology: a systematic review.1 passage
• Self-harm in a primary care cohort of older people: incidence, clinical management, and risk of suicide and other causes of death.1 passage
• Short-term and long-term effects of psychosocial therapy for people after deliberate self-harm: a register-based, nationwide multicentre study using propensity score matching.1 passage
• Side-effects associated with ketamine use in depression: a systematic review.1 passage
• Sleep disturbance and psychiatric disorders.1 passage
• Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.1 passage
• Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study.1 passage
• Social correlates of mental, neurological, and substance use disorders in China and India: a review.1 passage
• Social determinants of mental disorders and the Sustainable Development Goals: a systematic review of reviews.1 passage
• Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (SUPEREDEN3): a single-blind, randomised controlled trial.1 passage
• Sociodemographic inequalities in depression among older adults: cross-sectional evidence from 18 countries.1 passage
• Specific phobias.1 passage
• Staging bipolar disorder: what data and what models are needed?1 passage
• Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.1 passage
• Strategies not accompanied by a mental health professional to address anxiety and depression in children and young people: a scoping review of range and a systematic review of effectiveness.1 passage
• Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies.1 passage
• Structure and neural mechanisms of catatonia.1 passage
• Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.1 passage
• Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.1 passage
• Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study.1 passage
• Suicide and poverty in low-income and middle-income countries: a systematic review.1 passage
• Suicide following presentation to hospital for non-fatal self-harm in the Multicentre Study of Self-harm: a long-term follow-up study.1 passage
• Suicide in Northern Ireland: epidemiology, risk factors, and prevention.1 passage
• Suicide in children and young people in England: a consecutive case series.1 passage
• Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry.1 passage
• Suicide in prisons: an international study of prevalence and contributory factors.1 passage
• Suicide prevention strategies revisited: 10-year systematic review.1 passage
• Suicide rates by ethnic group among patients in contact with mental health services: an observational cohort study in England and Wales.1 passage
• Suicide risk and absconding in psychiatric hospitals with and without open door policies: a 15 year, observational study.1 passage
• Suicide risk assessment in UK mental health services: a national mixed-methods study.1 passage
• Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries.1 passage
• Suitability of measurements used to assess mental health outcomes in men and women trafficked for sexual and labour exploitation: a systematic review.1 passage
• Supporting recovery in patients with psychosis through care by community-based adult mental health teams (REFOCUS): a multisite, cluster, randomised, controlled trial.1 passage
• Supporting the parents of children and young people with anxiety and depressive disorders is an opportunity not to be missed: a scoping review.1 passage
• Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.1 passage
• Tapering of SSRI treatment to mitigate withdrawal symptoms.1 passage
• Targeting the biased brain: non-invasive brain stimulation to ameliorate cognitive control.1 passage
• Temporal changes in the incidence of treated psychiatric and neurodevelopmental disorders during adolescence: an analysis of two national Finnish birth cohorts.1 passage
• The BASIC group: closing mental health-care gaps for children.1 passage
• The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.1 passage
• The antecedents and outcomes of persistent and remitting adolescent depressive symptom trajectories: a longitudinal, population-based English study.1 passage
• The application of mHealth to mental health: opportunities and challenges.1 passage
• The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study.1 passage
• The association between first abortion and first-time non-fatal suicide attempt: a longitudinal cohort study of Danish population registries.1 passage
• The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis.1 passage
• The association between loneliness and depressive symptoms among adults aged 50 years and older: a 12-year population-based cohort study.1 passage
• The association between paternal and adolescent depressive symptoms: evidence from two population-based cohorts.1 passage
• The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial.1 passage
• The blood-brain barrier in psychosis.1 passage
• The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises?1 passage
• The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990-2017.1 passage
• The burden of mental ill health associated with childhood maltreatment in the UK, using The Health Improvement Network database: a population-based retrospective cohort study.1 passage
• The case for improved care and provision of treatment for people with first-episode mania.1 passage
• The challenge of ensuring affordability, sustainability, consistency, and adaptability in the common metrics agenda.1 passage
• The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.1 passage
• The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.1 passage
• The effect of VISHRAM, a grass-roots community-based mental health programme, on the treatment gap for depression in rural communities in India: a population-based study.1 passage
• The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.1 passage
• The effect of flexible assertive community treatment in Denmark: a quasi-experimental controlled study.1 passage
• The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis.1 passage
• The epidemiology of diabetes in psychotic disorders.1 passage
• The epidemiology of psychiatric disorders in Africa: a scoping review.1 passage
• The epidemiology of trauma and post-traumatic stress disorder in a representative cohort of young people in England and Wales.1 passage
• The fragmented self: imbalance between intrinsic and extrinsic self-networks in psychotic disorders.1 passage
• The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.1 passage
• The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019.1 passage
• The importance of developmental field trials in the revision of psychiatric classifications.1 passage
• The increasing global health priority of substance use in young people.1 passage
• The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study.1 passage
• The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.1 passage
• The management of adult psychiatric emergencies in low-income and middle-income countries: a systematic review.1 passage
• The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts.1 passage
• The need to show minimum clinically important differences in Alzheimer's disease trials.1 passage
• The paranoia as defence model of persecutory delusions: a systematic review and meta-analysis.1 passage
• The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.1 passage
• The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.1 passage
• The role of epigenetics in psychological resilience.1 passage
• The role of global traditional and complementary systems of medicine in the treatment of mental health disorders.1 passage
• The role of global traditional and complementary systems of medicine in treating mental health problems.1 passage
• The role of job strain in understanding midlife common mental disorder: a national birth cohort study.1 passage
• The serotonin transporter in psychiatric disorders: insights from PET imaging.1 passage
• The ubiquitin proteasome system and schizophrenia.1 passage
• Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial.1 passage
• Thinking about suicidal thinking.1 passage
• Thinking, believing, and hallucinating self in schizophrenia.1 passage
• Time-varying associations of pre-migration and post-migration stressors in refugees' mental health during resettlement: a longitudinal study in Australia.1 passage
• Time-varying associations of suicide with deployments, mental health conditions, and stressful life events among current and former US military personnel: a retrospective multivariate analysis.1 passage
• Towards diagnostic markers for the psychoses.1 passage
• Towards understanding atypical social affiliation in psychopathy.1 passage
• Traditional, complementary, and alternative medicine approaches to mental health care and psychological wellbeing in India and China.1 passage
• Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study.1 passage
• Trajectories of prescription drug misuse during the transition from late adolescence into adulthood in the USA: a national longitudinal multicohort study.1 passage
• Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis.1 passage
• Trajectories of suicidal ideation in patients with first-episode psychosis: secondary analysis of data from the OPUS trial.1 passage
• Trauma-informed care for adult survivors of developmental trauma with psychotic and dissociative symptoms: a systematic review of intervention studies.1 passage
• Traumatic brain injury: a potential cause of violent crime?1 passage
• Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.1 passage
• Uncovering the realities of delusional experience in schizophrenia: a qualitative phenomenological study in Belgium.1 passage
• Understanding suicidal ideation and behaviour in individuals with chronic pain: a review of the role of novel transdiagnostic psychological factors.1 passage
• Understanding the substance use of autistic adolescents and adults: a mixed-methods approach.1 passage
• Untreated help seekers in addiction services: an opportunity to reach under-served groups in research.1 passage
• Variation in compulsory psychiatric inpatient admission in England: a cross-classified, multilevel analysis.1 passage
• Variations in patterns of involuntary hospitalisation and in legal frameworks: an international comparative study.1 passage
• Violence against women and mental health.1 passage
• Violence and mental disorders: a structured review of associations by individual diagnoses, risk factors, and risk assessment.1 passage
• Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.1 passage
• What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?1 passage
• Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones.1 passage
• Why is depression more common among women than among men?1 passage
• Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA.1 passage
• Why young people's substance use matters for global health.1 passage
• Workplace mental health training for managers and its effect on sick leave in employees: a cluster randomised controlled trial.1 passage
• Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.1 passage